The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation

Journal of Controlled Release

Volumn 49, Issue 2-3, 1997, Pages 149-156

  Ho, Hsiu O ^a   Liu, Cheng Hsiung ^b   Lin, Hua Mei ^c   Sheu, Ming Thau ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

Bioavailability; Correlation; Diclofenac sodium; Dissolution; Matrix tablet

Indexed keywords

DICLOFENAC;

ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; PRIORITY JOURNAL; TABLET DISINTEGRATION TIME; VISCOSITY;

EID: 0031460612     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00067-9     Document Type: Article

References (12)

1. Todd A., Sorkin E.M. Diclofenac sodium, a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs. 35:1988;244-285.
2. Fowler D., Shadforth M.F., Rook P.R., John V.A. Plasma and synovial fluid concentration of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur. J. Clin. Pharmacol. 25:1983;389-394.
3. Cross W., Krob J., Krebs A., Zoller H. Diclofenac sodium, blood concentration of the slow-release form and influence on the metabolism of kallikrein. Arzneim.-Forsch. Drug Res. 24:1984;1327-1329.
4. Lucker W., Schnitker J. New sustained release formulation of diclofenac sodium for treatment of rheumatic disease. Therapiewoche. 35:1985;524-528.
5. Salah I., Sharkaw M. A multicentre study of diclofenac disorders in the Kingdom of Saudi Arabia. J. Int. Med. Res. 12:1985;244-249.
6. Raz I., Hussein Z., Samara E., Ben-David J. Comparative pharmacokinetic analysis of a novel sustained release dosage form of diclofenac sodium in healthy subjects. Int. J. Clin. Pharmacol. Ther. Toxicol. 26:1988;246-248.
7. Raid E., Sawchuk R. Relative bioavailability and effect of food on plasma level of diclofenac sodium following a single dose of Voltaren 100 mg. Pharm. Res. 6:1989;s-229.
8. Suleiman S., Abdulahameed M. A study on the relative bioavailability of a sustained release formulation of diclofenac sodium. Int. J. Clin. Pharmacol. Ther. Toxicol. 27:1989;276-279.
9. Liu H., Kao Y.H., Chen S.C., Sokoloski T.D., Sheu M.T. In-vitro and in-vivo studies of diclofenac sodium controlled-release matrix tablets. J. Pharm. Pharmacol. 47:1995;360-364.
10. Sheu M.T., Chou H.L., Kao C.C., Liu C.H., Sokoloski T.D. Dissolution of diclofenac sodium from matrix tablets. Int. J. Pharm. 85:1992;57-63.
11. Chan H., Mojaverian P., Ziehmer B.A., John V.A. Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteer. Pharm. Res. 7:1990;1026-1032.
12. Said A., Sharaf A.A. Pharmacokinetics of diclofenac sodium using a developed HPLC method. Arzneim.-Forsch. Drug Res. 31:1989;2089-2092.